Chinook Therapeutics Inc
Biotechnology
Healthcare
KDNY
71.59 M shares
NASDAQ US
traded
10 Aug 2023
listed
yes
open
40.31
52 week high
40.39
high
40.51
52 week low
18.19
previous Close
40.30
P/E ratio
market cap
2.71 B
div yield
0
net incoming
-66.94 M
0.00 %
net profit margin
-6641.27 %
-6641.00 %
operating incoming
-72.63 M
0.00 %
net change in cash
8.65 M
0.00 %
cash on hand
127 M
0.00 %
cost of revenue
433 K
0.00 %
top